Literature DB >> 35798390

Quantifying Brain Iron in Hereditary Hemochromatosis Using R2* and Susceptibility Mapping.

S K Sethi1,2, S Sharma3, S Gharabaghi2, D Reese4, Y Chen5, P Adams6, M S Jog3, E M Haacke7,2.   

Abstract

BACKGROUND AND
PURPOSE: Brain iron dyshomeostasis is increasingly recognized as an important contributor to neurodegeneration. Hereditary hemochromatosis is the most commonly inherited disorder of systemic iron overload. Although there is an increasing interest in excessive brain iron deposition, there is a paucity of evidence showing changes in brain iron exceeding that in healthy controls. Quantitative susceptibility mapping and R2* mapping are established MR imaging techniques that we used to noninvasively quantify brain iron in subjects with hereditary hemochromatosis.
MATERIALS AND METHODS: Fifty-two patients with hereditary hemochromatosis and 47 age- and sex-matched healthy controls were imaged using a multiecho gradient-echo sequence at 3T. Quantitative susceptibility mapping and R2* data were generated, and regions within the deep gray matter were manually segmented. Mean susceptibility and R2* relaxation rates were calculated for each region, and iron content was compared between the groups.
RESULTS: We noted elevated iron levels in patients with hereditary hemochromatosis compared with healthy controls using both R2* and QSM methods in the caudate nucleus, putamen, pulvinar thalamus, red nucleus, and dentate nucleus. Additionally, the substantia nigra showed increased susceptibility while the thalamus showed an increased R2* relaxation rate compared with healthy controls, respectively.
CONCLUSIONS: Both quantitative susceptibility mapping and R2* showed abnormal levels of brain iron in subjects with hereditary hemochromatosis compared with controls. Quantitative susceptibility mapping and R2* can be acquired in a single MR imaging sequence and are complementary in quantifying deep gray matter iron.
© 2022 by American Journal of Neuroradiology.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35798390      PMCID: PMC9262054          DOI: 10.3174/ajnr.A7560

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   4.966


  49 in total

Review 1.  Haemochromatosis.

Authors:  Pierre Brissot; Antonello Pietrangelo; Paul C Adams; Barbara de Graaff; Christine E McLaren; Olivier Loréal
Journal:  Nat Rev Dis Primers       Date:  2018-04-05       Impact factor: 52.329

Review 2.  HFE gene variants affect iron in the brain.

Authors:  Wint Nandar; James R Connor
Journal:  J Nutr       Date:  2011-02-23       Impact factor: 4.798

3.  Iron quantification in Parkinson's disease using an age-based threshold on susceptibility maps: The advantage of local versus entire structure iron content measurements.

Authors:  Sean K Sethi; Shawn J Kisch; Kiarash Ghassaban; Ali Rajput; Alex Rajput; Paul S Babyn; Saifeng Liu; Peter Szkup; E Mark Haacke
Journal:  Magn Reson Imaging       Date:  2018-10-13       Impact factor: 2.546

4.  Gender and iron genes may modify associations between brain iron and memory in healthy aging.

Authors:  George Bartzokis; Po H Lu; Kathleen Tingus; Douglas G Peters; Chetan P Amar; Todd A Tishler; J Paul Finn; Pablo Villablanca; Lori L Altshuler; Jim Mintz; Elizabeth Neely; James R Connor
Journal:  Neuropsychopharmacology       Date:  2011-03-09       Impact factor: 7.853

5.  Measuring iron in the brain using quantitative susceptibility mapping and X-ray fluorescence imaging.

Authors:  Weili Zheng; Helen Nichol; Saifeng Liu; Yu-Chung N Cheng; E Mark Haacke
Journal:  Neuroimage       Date:  2013-04-13       Impact factor: 6.556

6.  Movement Disorders Associated With Hemochromatosis.

Authors:  Niraj Kumar; Philippe Rizek; Bekim Sadikovic; Paul C Adams; Mandar Jog
Journal:  Can J Neurol Sci       Date:  2016-11       Impact factor: 2.104

Review 7.  Hemochromatosis: pathophysiology, evaluation, and management of hepatic iron overload with a focus on MRI.

Authors:  Shmuel Golfeyz; Sara Lewis; Ilan S Weisberg
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2018-07-19       Impact factor: 3.869

8.  In Vivo MRI Mapping of Brain Iron Deposition across the Adult Lifespan.

Authors:  Julio Acosta-Cabronero; Matthew J Betts; Arturo Cardenas-Blanco; Shan Yang; Peter J Nestor
Journal:  J Neurosci       Date:  2016-01-13       Impact factor: 6.167

9.  Regional High Iron in the Substantia Nigra Differentiates Parkinson's Disease Patients From Healthy Controls.

Authors:  Kiarash Ghassaban; Naying He; Sean Kumar Sethi; Pei Huang; Shengdi Chen; Fuhua Yan; Ewart Mark Haacke
Journal:  Front Aging Neurosci       Date:  2019-05-27       Impact factor: 5.750

10.  Iron Content in Deep Gray Matter as a Function of Age Using Quantitative Susceptibility Mapping: A Multicenter Study.

Authors:  Yan Li; Sean K Sethi; Chunyan Zhang; Yanwei Miao; Kiran Kumar Yerramsetty; Vinay Kumar Palutla; Sara Gharabaghi; Chengyan Wang; Naying He; Jingliang Cheng; Fuhua Yan; Ewart Mark Haacke
Journal:  Front Neurosci       Date:  2021-01-06       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.